JP Stock MarketDetailed Quotes

4521 Kaken Pharmaceutical

Watchlist
  • 3451.0
  • +8.0+0.23%
20min DelayMarket Closed May 17 15:00 JST
130.69BMarket Cap23.83P/E (Static)

Kaken Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kaken Pharmaceutical Earnings Date

Currency: JPY

Period

FY2024 Annual Report

May 14, 2024

Revenue(YoY)

72.04B

-1.29%
NI to Common Holders(YoY)

8.03B

+47.52%
Analyst Rating

Hold

Aug 30, 2023

Kaken Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----
Aug 3, 20222023/Q118.197B / ----
Feb 3, 20222022/Q320.120B / ----
Aug 3, 20212022/Q118.453B / ----
Feb 3, 20212021/Q320.293B / ----
Aug 3, 20202021/Q118.070B / ----
Feb 3, 20202020/Q325.008B / ----
Aug 1, 20192020/Q122.335B / ----
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q318.514B / ----
Aug 4, 20232024/Q118.150B / ----
Feb 3, 20232023/Q318.754B / ----
Aug 3, 20222023/Q118.197B / ----
Feb 3, 20222022/Q320.120B / ----
Aug 3, 20212022/Q118.453B / ----
Feb 3, 20212021/Q320.293B / ----
Aug 3, 20202021/Q118.070B / ----
Feb 3, 20202020/Q325.008B / ----
Aug 1, 20192020/Q122.335B / ----

Unlock Free Earnings Estimates

Kaken Pharmaceutical Earnings Reports

  • Kaken Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

    May 13 23:30

  • Scientific Research Pharmaceutical: Confirmation Letter

    Feb 12 19:14

  • Scientific Research & Pharmaceutical: Quarterly Report - 104th Term 3rd Quarter (2023/10/01 - 2023/12/31)

    Feb 12 19:13

  • Kaken Pharmaceutical: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

    Feb 5 22:30

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 30, 2023

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      100.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg